17-05-2012Sandoz to acquire Fougera Pharmaceuticals, becoming the number one generic dermatology medicines company globally and in the US

16-05-2012Sandoz Canada makes strong progress in supply of critical medicines

26-03-2012Sandoz Canada restarts shipments of 2mg/mL, 1 mL morphine ampoules with 100% product passing inspection

23-03-2012Sandoz Canada initiates precautionary recall for one morphine lot and works with Health Canada to quickly resupply product

12-03-2012Boucherville Production Partially Restarted

06-03-2012Update on the March 4th fire at the Boucherville plant

16-02-2011Sandoz launches Valsartan and Valsartan HCT

Sandoz launches Valsartan and Valsartan HCT, the generic versions of Diovan® and Diovan-HCT^TM 

05-01-2011Sandoz launches Sandoz Tamsulosin CR

Sandoz launches Sandoz Tamsulosin CR, the generic version of Flomax®CR

08-03-2010Sandoz Canada has a new President!

Sandoz Canada is proud to announce that as of April 1^st, Michel Robidoux will become the new President of Sandoz Canada.

01-10-2009Sandoz Canada inaugurates new head office in Boucherville

 Sandoz Canada Inc., a leader in the generic drug industry, inaugurated its new head office on August 29 in Boucherville. At an open house for employees and their families, Sandoz celebrated the official opening of the four-storey building, constructed following a $12 million investment.

22-04-2009Sandoz Canada receives approval for Omnitrope™

Sandoz Canada receives approval for recombinant human-growth hormone Omnitrope™, the first Subsequent Entry Biologic in Canada